Jefferies Boosts Price Target on Tenet Healthcare (THC) to $6.50

Jefferies raised its price target on Buy-rated Tenet Healthcare (NYSE: THC) earlier from $6 to $6.50.

The firm comments, "We do not expect the departure of CFO Biggs Porter to Fluor to disrupt THC's strategic focus, particularly since CEO Trevor Fetter is assuming the CFO role on an interim basis. We are updating our FY12 and FY13 earnings forecasts. Maintaining Buy/$6.50PT (up from $6)."

The firm cut FY12 EPS from $0.52 to $0.50.

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $5.43 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
• Home Depot (HD) PT Raised to $340 at Stifel Amid 'Sea Change in Investor Sentiment'
• Analog Devices (ADI) Reiterated at Overweight by Cantor Fitzgerald: Beat and Raise Expected